𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?

✍ Scribed by Katherine H Fiala; Jacqueline Whetteckey; Bala V Manyam

Book ID
117751886
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
99 KB
Volume
9
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Parkinson's disease, levodopa-use and th
Parkinson's disease, levodopa-use and the risk of melanoma
✍ J.-D. Vermeij; A. Winogrodzka; J. Trip; W.E.J. Weber πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 98 KB

Since the early 1970s, the literature has suggested an association between Parkinson's Disease (PD) and/ or levodopa-use and an increased risk for the development of malignant melanoma. In some countries, this possible association has even led to a warning in the drug insert leaflet of the possible

Domperidone and levodopa in Parkinson's
Domperidone and levodopa in Parkinson's disease.
✍ JS Shindler; GT Finnerty; K Towlson; AL Dolan; CL Davies; JD Parkes πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 428 KB
Malignant melanoma in early Parkinson's
Malignant melanoma in early Parkinson's disease: The DATATOP trial
✍ Radu Constantinescu; Megan Romer; Karl Kieburtz πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 53 KB

## Abstract The available epidemiological data on the incidence of malignant melanoma in Parkinson's disease are contradictory. The role of levodopa therapy in this context has been debated. We identified all known cases of malignant melanoma (N = 5) in the DATATOP clinical trial cohort and compare